Global Fluorescent in Situ Hybridization Technique Market Growth (Status and Outlook) 2025-2031

The global Fluorescent in Situ Hybridization Technique market size is predicted to grow from US$ 1150 million in 2025 to US$ 1681 million in 2031; it is expected to grow at a CAGR of 6.5% from 2025 to 2031.

Fluorescence in situ hybridization technique(FISH) is a non radioactive molecular cytogenetic technique developed on the basis of radioactive in situ hybridization technology. It uses fluorescent labeling instead of isotope labeling in situ hybridization method, and is a molecular diagnostic technique that uses fluorescent labeled DNA probes to detect specific DNA sequences in cells, tissues, and tumors.

United States market for Fluorescent in Situ Hybridization Technique is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Fluorescent in Situ Hybridization Technique is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Fluorescent in Situ Hybridization Technique is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Fluorescent in Situ Hybridization Technique players cover ThermoFisher Scientific, Agilent Technologies, Abnova Corporation, Creative Bioarray, Precision Medicine Group, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LPI (LP Information)' newest research report, the “Fluorescent in Situ Hybridization Technique Industry Forecast” looks at past sales and reviews total world Fluorescent in Situ Hybridization Technique sales in 2024, providing a comprehensive analysis by region and market sector of projected Fluorescent in Situ Hybridization Technique sales for 2025 through 2031. With Fluorescent in Situ Hybridization Technique sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Fluorescent in Situ Hybridization Technique industry.

This Insight Report provides a comprehensive analysis of the global Fluorescent in Situ Hybridization Technique landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Fluorescent in Situ Hybridization Technique portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Fluorescent in Situ Hybridization Technique market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Fluorescent in Situ Hybridization Technique and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Fluorescent in Situ Hybridization Technique.

This report presents a comprehensive overview, market shares, and growth opportunities of Fluorescent in Situ Hybridization Technique market by product type, application, key players and key regions and countries.

Segmentation by Type:
Cellular Chromosome FISH
Tissue Chromosome FISH

Segmentation by Application:
Molecular Biology Research
Medical Testing

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
ThermoFisher Scientific
Agilent Technologies
Abnova Corporation
Creative Bioarray
Precision Medicine Group
Creative Biolabs
Cell Line Genetics
Creative BioMart
Genemed
Sysmex Group
Genetics Associates Incorporated
Bruker Spatial Biology
Cell Culture Company
Molecular Diagnostic Services
Creative Biogene
CD Genomics
Beijing Abace Biology
Shanghai Medicilon

Please note: The report will take approximately 2 business days to prepare and deliver.